DEF: Natural Health Trends Sets 2026 Annual Meeting Agenda
Definitive Proxy Statement
Natural Health Trends Corp. announces its 2026 annual meeting to elect directors, approve a new equity incentive plan, and ratify its independent auditor.
Summary
- The 2026 annual meeting of stockholders will be held on May 7, 2026, at the company's office in Hong Kong.
- Stockholders will vote on the election of four directors, approval of the Natural Health Trends Corp. 2026 Equity Incentive Plan, and ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
- The Board of Directors recommends voting for all proposed items.
- As of March 10, 2026, 8,577,848 shares of common stock were outstanding, with a quorum requiring the presence of holders representing at least 4,288,925 shares.
- The company reported a net loss of $882,000 in 2025, a significant decline from net income of $572,000 in 2024 and $568,000 in 2023.
- Total Shareholder Return (TSR) decreased from $194.17 in 2023 to $151.21 in 2025, based on an initial $100 investment on December 31, 2022.
- The proposed 2026 Equity Incentive Plan seeks approval for 1,100,000 shares, representing an estimated dilution of 12.8% based on current outstanding shares.
- Executive and non-employee director phantom share awards granted in April 2025 did not meet performance conditions in any of the three quarters they were in effect during 2025, leading to forfeitures of 46,818 phantom shares for the President and 15,672 for the CFO.
- Two current directors, Yiu T. Chan and Lucy N. Nduati, are not standing for re-election, and Ellen Sun has been nominated as a new independent director.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing with a negative sentiment due to the significant decline in net income to a loss in 2025 and a consistent decrease in Total Shareholder Return over the past three years, despite the routine nature of a proxy statement.
Positives
- All Section 16(a) filing requirements for officers, directors, and greater than ten percent beneficial owners were satisfied in 2025.
- The Board of Directors has a robust risk oversight process, conducted through the Board and its various committees.
- The company has a comprehensive Worldwide Code of Business Conduct and an Insider Trading Policy that explicitly prohibits employees and directors from engaging in hedging transactions with company stock.
- The proposed 2026 Equity Incentive Plan's three-year average burn rate of 0.0028% (from 2023 through 2025) is well below the Institutional Shareholder Services, Inc. (ISS) burn rate cap of 1.57% applied to the company's industry.
- The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for 2026 ensures continuity, as CBIZ acquired the attest business of the previous auditor, Marcum LLP, and retained substantially all relevant personnel.
- The new director nominee, Ellen Sun, brings extensive background in financial reporting and compliance matters, and is expected to qualify as an independent director and an audit committee financial expert.
Negatives
- The company reported a net loss of $882,000 in 2025, a significant deterioration from net income of $572,000 in 2024 and $568,000 in 2023.
- The company's Total Shareholder Return (TSR) has consistently declined, with an initial $100 investment on December 31, 2022, decreasing to $151.21 by 2025 from $194.17 in 2023.
- Performance conditions for executive and non-employee director phantom share awards granted in April 2025 were not met in any of the three quarters they were in effect during 2025, leading to forfeitures of 46,818 phantom shares for the President and 15,672 for the CFO.
- Two current directors, Yiu T. Chan and Lucy N. Nduati, are not standing for re-election, indicating a change in board composition.
- The Compensation Committee and Nominating and Corporate Governance Committee did not hold formal meetings during fiscal year 2025, instead acting solely by unanimous written consent.
Risks
- The company operates in a competitive market, and its success depends on its ability to attract, retain, and reward talented and competent employees and other service providers.
- The proposed 2026 Equity Incentive Plan, if approved, will result in an estimated dilution of approximately 12.8% to existing shareholders.
- The vesting of certain executive and director equity awards is contingent upon achieving specific financial performance conditions, such as positive operating profit of at least $150,000 or $300,000 per quarter, and stock appreciation, which introduces risk of forfeiture if these targets are not met.
- There is a potential for an excise tax under Section 4999 of the Internal Revenue Code to be imposed upon participants in connection with awards during a change in control, although the company provides for an Excise Gross-Up Payment.
- Awards issued under the 2026 Equity Incentive Plan may be characterized by the Internal Revenue Service (IRS) as deferred compensation under the Code, potentially resulting in additional taxes, interest, and penalties for participants, which the company will not reimburse.
Future Outlook
The company intends for the 2026 Equity Incentive Plan to attract, motivate, and retain management and other key personnel, aligning their interests with stockholders through equity-based compensation tied to annual, long-term, and strategic goals. The Board will evaluate appropriate steps regarding option grant timing if the company decides to grant new awards of stock options in the future.
Management Comments
- The Board of Directors believes that the award of incentive compensation continues to be a factor in attracting, motivating and retaining management and other key personnel and that it aligns their interests with those of the Companys stockholders through equity-based compensation that rewards performance based on annual, long-term, and strategic goals.
- The Board of Directors believes that the Equity Plan will serve a critical role in attracting and motivating valuable people that will be essential to the future success of the Company.
- The Compensation Committee believes that the potential deductibility of the compensation payable under the Equity Plan and its other compensation plans and arrangements should be only one of a number of relevant factors taken into consideration in establishing those plans and arrangements for our executive officers and not the sole governing factor.
Industry Context
StockSavvy.ai notes that the direct selling and health and wellness industry, in which Natural Health Trends Corp. operates, often relies heavily on incentive-based compensation to motivate its sales force and corporate leadership. The proposed 2026 Equity Incentive Plan, with its focus on attracting and retaining talent, reflects a common strategy in this competitive sector to align employee interests with company performance, especially given the recent decline in net income and TSR. The low burn rate for equity awards suggests a conservative approach to equity dilution compared to industry benchmarks.
Comparison to Industry Standards
- The company's three-year average burn rate of 0.0028% is significantly below the Institutional Shareholder Services, Inc. (ISS) burn rate cap of 1.57% applied to its industry, indicating a relatively low rate of equity dilution from awards compared to peers.
- The use of performance-based phantom shares for executive and director compensation, tied to operating profit and stock appreciation, aligns with best practices in corporate governance to link pay to performance, although the failure to meet these conditions in 2025 highlights challenges in achieving set targets.
- The 'double trigger' severance arrangements for executives in a change of control scenario are a common feature in employment agreements, designed to protect executive interests while ensuring continuity during transitions, consistent with practices seen in companies like Herbalife Nutrition Ltd. or Nu Skin Enterprises, Inc.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Yiu T. Chan | NA | May 7, 2026 (after annual meeting) | Not standing for re-election. |
| Director | Lucy N. Nduati | NA | May 7, 2026 (after annual meeting) | Not standing for re-election. |
| Director | NA | Ellen Sun | May 7, 2026 (if elected) | Nominated for election to the Board of Directors, bringing financial reporting and compliance expertise. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | Two current directors, Yiu T. Chan and Lucy N. Nduati, are not standing for re-election, and Ellen Sun has been nominated as a new independent director. | May 7, 2026 (upon election at annual meeting) | This will result in a change in the composition of the Board, with the addition of a director with strong financial and compliance background, potentially enhancing oversight in these areas. |
| Equity Compensation Plan | Proposal to approve the Natural Health Trends Corp. 2026 Equity Incentive Plan, replacing the expiring 2016 plan, to continue offering equity-based incentives. | May 7, 2026 (upon stockholder approval) | Aims to attract, retain, and motivate key personnel by aligning their interests with stockholders, but introduces potential dilution of 12.8%. |
| Auditor Appointment | Ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for the year ending December 31, 2026, following their engagement in 2025 after acquiring Marcum LLP's attest business. | December 31, 2026 (fiscal year end) | Ensures continuity of audit services, as CBIZ acquired the previous auditor's attest business and personnel, maintaining audit quality and independence. |
| Committee Activity | The Compensation Committee and Nominating and Corporate Governance Committee did not meet during fiscal 2025, instead acting by unanimous written consent. | NA | While legally permissible, a lack of formal meetings for key committees could be perceived as less robust oversight compared to committees that regularly convene. |
| Clawback Policy | The 2026 Equity Incentive Plan includes a compensation recovery (clawback) provision allowing the company to recover awards if performance criteria were not met or if based on restated financial results due to material noncompliance. | May 7, 2026 (upon stockholder approval of the plan) | Strengthens accountability for executives and directors by linking compensation directly to accurate financial reporting and performance, aligning with evolving regulatory expectations. |
Stakeholder Impact
- Shareholders: Potential dilution from the 2026 Equity Incentive Plan (12.8%). Negative impact from declining TSR and net loss in 2025. Opportunity to vote on key governance matters.
- Employees/Officers: Continuation of equity incentive programs (2026 Equity Incentive Plan) for motivation and retention. Compensation tied to performance metrics, with risk of forfeiture if targets are not met. Severance protections in case of termination or change of control.
- Directors: Changes in board composition with two directors not standing for re-election and one new nominee. Compensation includes cash retainers and performance-based phantom shares.
- Auditors: CBIZ CPAs P.C. confirmed as independent registered public accounting firm, ensuring continuity of audit services.
Next Steps
- Stockholders are to vote on director elections, the 2026 Equity Incentive Plan, and auditor ratification at the annual meeting on May 7, 2026.
- The 2016 Equity Incentive Plan will expire on April 7, 2026, with no further awards to be made under it.
- The 2026 Equity Incentive Plan will become effective upon stockholder approval at the annual meeting.
- The Audit Committee will reconsider the retention of CBIZ CPAs P.C. if stockholders do not ratify their appointment, though the decision is not binding.
- Stockholders interested in submitting proposals for the 2027 annual meeting must adhere to specific deadlines: November 24, 2026, for SEC Rule 14a-8 proposals; February 6, 2027, for bylaw nominations/proposals; and March 8, 2027, for Rule 14a-19 notices.
Key Dates
| Date | Description |
|---|---|
| 2022-12-31 | Base date for Total Shareholder Return (TSR) calculation for initial $100 investment. |
| 2023-02-07 | Compensation Committee granted 124,850 phantom shares to Chris T. Sharng and 41,788 phantom shares to Timothy S. Davidson under the Phantom Equity Plan. |
| 2023-12-31 | End of fiscal year for which company reported $568,000 net income and TSR of $194.17. |
| 2024-11-01 | CBIZ acquired the attest business of Marcum LLP. |
| 2024-12-31 | End of fiscal year for which company reported $572,000 net income and TSR of $179.59. Phantom shares granted on February 7, 2023, were fully vested by this date. |
| 2025-03-13 | Marcum LLP resigned as independent registered public accounting firm, and CBIZ CPAs P.C. was engaged for fiscal year ending December 31, 2025. |
| 2025-04-01 | Board of Directors approved the grant of 124,850 phantom shares to Chris T. Sharng, 41,788 phantom shares to Timothy S. Davidson, and phantom shares to non-employee directors under the Phantom Equity Plan. |
| 2025-05-06 | Date of the previous annual stockholders meeting. |
| 2025-12-31 | End of fiscal year for which company reported a net loss of $882,000 and TSR of $151.21. Also, the date for equity compensation plan information and director compensation. |
| 2026-03-10 | Record date for stockholders entitled to vote at the 2026 annual meeting. |
| 2026-03-19 | Board of Directors approved the 2026 Equity Incentive Plan. |
| 2026-03-24 | Date proxy statement was first sent or given to stockholders. |
| 2026-04-07 | Expiration date of the 2016 Equity Incentive Plan. |
| 2026-05-07 | Date of the 2026 annual meeting of stockholders. |
| 2026-11-24 | Deadline for stockholder proposals to be included in the 2027 proxy statement under SEC rules. |
| 2027-02-06 | Deadline for stockholder nominations or business proposals for the 2027 annual meeting under company bylaws (assuming meeting date is within normal range). |
| 2027-03-08 | Deadline for notice of proxy solicitation for director nominees under Rule 14a-19 for the 2027 annual meeting (assuming meeting date is within normal range). |
Recommendation
sellThe company's financial performance shows a concerning trend, with a shift from net income to a significant net loss in 2025 and a consistent decline in Total Shareholder Return over the past three years. The failure of executive and director performance-based equity awards to vest due to unmet conditions further underscores operational challenges. While the proxy statement outlines routine governance matters and a new equity plan, the underlying financial deterioration suggests fundamental issues that could negatively impact future share price. A seasoned investor would likely view these financial results as a strong signal to sell or avoid the stock until a clear path to profitability and improved shareholder returns is demonstrated.
Keywords
Natural Health Trends Corp, NHTC, Proxy Statement, DEF 14A, Annual Meeting, Director Election, Equity Incentive Plan, Executive Compensation, Corporate Governance, Audit Firm, Financial Performance, Net Income, Total Shareholder Return, Phantom Shares, Stock Awards, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.